NO20061953L - Melaninkonsentrerende hormonantagonister - Google Patents
Melaninkonsentrerende hormonantagonisterInfo
- Publication number
- NO20061953L NO20061953L NO20061953A NO20061953A NO20061953L NO 20061953 L NO20061953 L NO 20061953L NO 20061953 A NO20061953 A NO 20061953A NO 20061953 A NO20061953 A NO 20061953A NO 20061953 L NO20061953 L NO 20061953L
- Authority
- NO
- Norway
- Prior art keywords
- concentrating hormone
- hormone antagonists
- melanin concentrating
- compounds
- appetite
- Prior art date
Links
- 101800002739 Melanin-concentrating hormone Proteins 0.000 title abstract 2
- ORRDHOMWDPJSNL-UHFFFAOYSA-N melanin concentrating hormone Chemical compound N1C(=O)C(C(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(NC(=O)C(N)CC(O)=O)C(C)O)CCSC)CSSCC(C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)C)C(O)=O)NC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C1CC1=CC=C(O)C=C1 ORRDHOMWDPJSNL-UHFFFAOYSA-N 0.000 title abstract 2
- 102000047659 melanin-concentrating hormone Human genes 0.000 title abstract 2
- 239000003667 hormone antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000036528 appetite Effects 0.000 abstract 2
- 235000019789 appetite Nutrition 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000505 pernicious effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/79—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50777303P | 2003-10-01 | 2003-10-01 | |
| US53664004P | 2004-01-15 | 2004-01-15 | |
| PCT/US2004/031631 WO2005033063A2 (en) | 2003-10-01 | 2004-09-24 | Melanin concentrating hormone antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061953L true NO20061953L (no) | 2006-06-13 |
Family
ID=34426018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061953A NO20061953L (no) | 2003-10-01 | 2006-05-02 | Melaninkonsentrerende hormonantagonister |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7304065B2 (pt) |
| EP (1) | EP1667958A2 (pt) |
| JP (1) | JP2007508303A (pt) |
| KR (1) | KR20060060047A (pt) |
| CN (1) | CN101068773A (pt) |
| AR (1) | AR045958A1 (pt) |
| AU (1) | AU2004278352B2 (pt) |
| BR (1) | BRPI0415051A (pt) |
| CA (1) | CA2540826A1 (pt) |
| CO (1) | CO5690589A2 (pt) |
| IL (1) | IL174370A0 (pt) |
| IS (1) | IS8360A (pt) |
| MA (1) | MA28079A1 (pt) |
| MX (1) | MXPA06003654A (pt) |
| NO (1) | NO20061953L (pt) |
| PE (1) | PE20050475A1 (pt) |
| RU (1) | RU2006110272A (pt) |
| SG (1) | SG146692A1 (pt) |
| TW (1) | TW200526554A (pt) |
| WO (1) | WO2005033063A2 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008001160A1 (en) * | 2006-06-23 | 2008-01-03 | The Procter & Gamble Company | Melanin concentrating hormone antagonists |
| DE602007006019D1 (de) * | 2006-06-28 | 2010-06-02 | Glaxo Group Ltd | Für die behandlung von durch den gpr38-rezeptor vermittelten krankheiten geeignete piperazinylderivate |
| WO2008044632A1 (en) * | 2006-10-06 | 2008-04-17 | Taisho Pharmaceutical Co., Ltd. | 1-naphthyl alkylpiperidine derivative |
| EP2216323A3 (en) * | 2007-04-27 | 2010-12-29 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| EP2025674A1 (de) * | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| TW201010997A (en) * | 2008-06-18 | 2010-03-16 | Pfizer Ltd | Nicotinamide derivatives |
| UY32442A (es) | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
| TW201040153A (en) * | 2009-02-13 | 2010-11-16 | Sanofi Aventis | Novel substituted tetrahydronaphthalenes, process for preparation thereof and use thereof as medicaments |
| CN102781914B (zh) * | 2010-01-06 | 2014-09-17 | 武田药品工业株式会社 | 吲哚衍生物 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206428A (en) * | 1989-11-16 | 1993-04-27 | Tanabe Seiyaku Co., Ltd. | Tetrahydronaphthalene derivatives and preparation thereof |
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| CA2155108A1 (en) * | 1993-02-12 | 1994-08-18 | John J. Baldwin | Nitrogen-containing spirocycles |
| WO1994027597A1 (en) * | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
| JPH10500960A (ja) | 1994-05-28 | 1998-01-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ１ｄ−アンタゴニスト活性を有するアミド誘導体 |
| DE4438029A1 (de) * | 1994-10-25 | 1996-05-02 | Thomae Gmbh Dr K | N.N-disubstituierte Benzocycloalkylamine, ihre Salze mit verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel |
| WO1996030333A1 (en) * | 1995-03-27 | 1996-10-03 | Smithkline Beecham Plc | Bicyclic amine derivatives and their use as anti-psychotic agents |
| DE19614718A1 (de) * | 1996-04-15 | 1997-10-16 | Hoechst Schering Agrevo Gmbh | Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel |
| HU225960B1 (en) | 1997-02-27 | 2008-01-28 | Takeda Pharmaceutical | Amine compounds, their production and use |
| US6747023B1 (en) * | 1998-08-11 | 2004-06-08 | Daiichi Pharmaceutical Co., Ltd. | Sulfonyl derivatives |
| EP1218336A2 (en) | 1999-09-20 | 2002-07-03 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
| EP1285651B1 (en) | 2000-04-28 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Melanin concentrating hormone antagonists |
| US7229986B2 (en) | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
| HK1054390B (en) | 2000-12-22 | 2006-01-06 | Schering Corporation | Piperidine mch antagonists and their use in the treatment of obesity |
| US6900329B2 (en) | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
| JP2005523237A (ja) | 2001-10-01 | 2005-08-04 | 大正製薬株式会社 | Ｍｃｈ受容体アンタゴニスト |
| WO2003035055A1 (en) | 2001-10-25 | 2003-05-01 | Schering Corporation | Mch antagonists for the treatment of obesity |
| IL161717A0 (en) | 2001-11-26 | 2004-09-27 | Schering Corp | Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| CA2468015A1 (en) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
| AU2002352868A1 (en) | 2001-11-27 | 2003-06-10 | Merck & Co., Inc. | 4-aminoquinoline compounds |
| ATE404190T1 (de) | 2001-12-04 | 2008-08-15 | Schering Corp | N-aryl-n'-arylcycloalkyl-harnstoff als mch antagonisten zur behandlung von fettleibigkeit |
| DE10238865A1 (de) | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| BR0315566A (pt) * | 2002-10-21 | 2005-08-23 | Janssen Pharmaceutica Nv | Tetralinas e indanos substituìdos |
| AU2004231070B2 (en) * | 2003-04-10 | 2008-02-14 | Amgen, Inc. | Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
-
2004
- 2004-09-24 AU AU2004278352A patent/AU2004278352B2/en not_active Expired - Fee Related
- 2004-09-24 BR BRPI0415051-1A patent/BRPI0415051A/pt not_active IP Right Cessation
- 2004-09-24 EP EP04789086A patent/EP1667958A2/en not_active Withdrawn
- 2004-09-24 CN CNA2004800284489A patent/CN101068773A/zh active Pending
- 2004-09-24 MX MXPA06003654A patent/MXPA06003654A/es unknown
- 2004-09-24 SG SG200807343-9A patent/SG146692A1/en unknown
- 2004-09-24 RU RU2006110272/04A patent/RU2006110272A/ru not_active Application Discontinuation
- 2004-09-24 WO PCT/US2004/031631 patent/WO2005033063A2/en not_active Ceased
- 2004-09-24 KR KR1020067006228A patent/KR20060060047A/ko not_active Ceased
- 2004-09-24 JP JP2006533994A patent/JP2007508303A/ja active Pending
- 2004-09-24 CA CA002540826A patent/CA2540826A1/en not_active Abandoned
- 2004-09-24 US US10/949,841 patent/US7304065B2/en not_active Expired - Fee Related
- 2004-09-30 AR ARP040103561A patent/AR045958A1/es not_active Application Discontinuation
- 2004-09-30 TW TW093129687A patent/TW200526554A/zh unknown
- 2004-10-01 PE PE2004000964A patent/PE20050475A1/es not_active Application Discontinuation
-
2006
- 2006-03-16 IL IL174370A patent/IL174370A0/en unknown
- 2006-03-17 IS IS8360A patent/IS8360A/is unknown
- 2006-03-31 MA MA28903A patent/MA28079A1/fr unknown
- 2006-04-11 CO CO06035263A patent/CO5690589A2/es not_active Application Discontinuation
- 2006-05-02 NO NO20061953A patent/NO20061953L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007508303A (ja) | 2007-04-05 |
| AU2004278352A1 (en) | 2005-04-14 |
| EP1667958A2 (en) | 2006-06-14 |
| SG146692A1 (en) | 2008-10-30 |
| US7304065B2 (en) | 2007-12-04 |
| AU2004278352B2 (en) | 2008-10-30 |
| CN101068773A (zh) | 2007-11-07 |
| RU2006110272A (ru) | 2007-11-10 |
| IL174370A0 (en) | 2006-08-01 |
| MXPA06003654A (es) | 2006-06-05 |
| TW200526554A (en) | 2005-08-16 |
| BRPI0415051A (pt) | 2006-11-28 |
| IS8360A (is) | 2006-03-17 |
| KR20060060047A (ko) | 2006-06-02 |
| PE20050475A1 (es) | 2005-10-05 |
| AR045958A1 (es) | 2005-11-16 |
| CA2540826A1 (en) | 2005-04-14 |
| MA28079A1 (fr) | 2006-08-01 |
| WO2005033063A3 (en) | 2007-03-22 |
| CO5690589A2 (es) | 2006-10-31 |
| WO2005033063A2 (en) | 2005-04-14 |
| US20050075324A1 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20120366A (es) | Proteínas de enlace a antigenos humanas que enlazan beta-klotho, receptores fgf y complejos de los mismos | |
| DK1638551T3 (da) | Immunosuppressive forbindelser og sammensætninger | |
| CR9291A (es) | Anticuerpos para interleucina-17f y otros antagonistas de la senalizacion de il-17f, y sus usos | |
| NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
| EA200601353A1 (ru) | Селективные модуляторы рецепторов эстрогена для лечения вазомоторных симптомов | |
| EP1962838A4 (en) | Farnesoid X RECEPTOR AGONISTS | |
| NZ594140A (en) | C5ar antagonists | |
| ATE399770T1 (de) | Tachykininrezeptorantagonisten | |
| SE0202241D0 (sv) | Novel Compounds | |
| CY1107368T1 (el) | Νεα παραγωγα 4-βενζυλιδενο-πιπεριδινης | |
| ATE435206T1 (de) | Heteroarylsulfonylstilbene als 5-ht2a- antagonisten | |
| UY27188A1 (es) | Uso de agonistas inversos de gabaa en combinación con agonistas parciales del receptor de nicotina, estrógenos, moduladores selectivos de estrógenos o vitamina e, para el tratamiento de trastornos cognitivos. | |
| NO20061953L (no) | Melaninkonsentrerende hormonantagonister | |
| MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| ECSP034860A (es) | 5-sustituidas-2-arilpiridinas como moduladores del factor 1 de liberación de corticotropina | |
| NO20053111L (no) | Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. | |
| DK1240326T3 (da) | Udlösende receptor der er involveret i naturlig cytotoxicitet medieret af humane naturlige dræberceller og antistoffer som identificerer denne receptor | |
| DK2257526T3 (da) | Spiro(5,5)undecan-derivater | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| ATE519498T1 (de) | Kombination aus somatostatin-analoga unterschiedlicher selektivität für humane somatostatin-rezeptor-subtypen | |
| MX2022016494A (es) | Anticuerpos anti-il13ra2. | |
| DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
| DE602004016150D1 (de) | Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta | |
| EP2152228A4 (en) | MULTIBLOCK COPOLYMER PROCESS WITH POLAR SOLVENTS | |
| ATE456953T1 (de) | Behandlung von amyotrophischer lateralsklerose mit pyrimethamin und analoga |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |